Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Fuji
Cerilliant
US Department of Justice
Argus Health
QuintilesIMS
US Army
Merck
Julphar

Generated: June 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 088290

« Back to Dashboard

NDA 088290 describes NANDROLONE DECANOATE, which is a drug marketed by Abraxis Pharm, Akorn, Luitpold Pharms Inc, and Watson Labs, and is included in ten NDAs. It is available from one supplier. Additional details are available on the NANDROLONE DECANOATE profile page.

The generic ingredient in NANDROLONE DECANOATE is nandrolone decanoate. There are fifteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the nandrolone decanoate profile page.
Summary for 088290
Tradename:NANDROLONE DECANOATE
Applicant:Abraxis Pharm
Ingredient:nandrolone decanoate
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength100MG/ML
Approval Date:Oct 3, 1983TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Cantor Fitzgerald
AstraZeneca
US Department of Justice
Chubb
Medtronic
Johnson and Johnson
McKesson
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.